CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,958,290 | +60.0% | 107,496 | +97.2% | 0.04% | +59.1% |
| Q2 2023 | $1,849,151 | -7.4% | 54,499 | -1.8% | 0.02% | -18.5% |
| Q1 2023 | $1,995,847 | +14.8% | 55,471 | -13.9% | 0.03% | 0.0% |
| Q2 2022 | $1,738,000 | -91.2% | 64,454 | -88.9% | 0.03% | -91.6% |
| Q1 2022 | $19,727,000 | +96.4% | 579,192 | +122.9% | 0.32% | +122.2% |
| Q4 2021 | $10,042,000 | – | 259,895 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|